Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Expert Opinion on Biological Therapy
|
October 6, 2017
Treating hematological malignancies with cell therapy: where are we now?
Elisa Landoni, Barbara Savoldo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors
Giovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15
Yuhui Chen, Chuang Sun, Elisa Landoni, et al.
Journal for Immunotherapy of Cancer
|
September 14, 2021
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
Justin T Huckaby, Elisa Landoni, Timothy M Jacobs, et al.
Nature Cancer
|
April 26, 2021
GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision
Kai Wang, Yuhui Chen, Sarah Ahn, et al.
Bioengineering & Translational Medicine
|
November 29, 2023
Utilizing induced neural stem cell-based delivery of a cytokine cocktail to enhance chimeric antigen receptor-modified T-cell therapy for brain cancer
Alex S Woodell, Elisa Landoni, Alain Valdivia, et al.
Cancer Immunology Research
|
November 14, 2019
A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor
Elisa Landoni, Christof C Smith, Giovanni Fucá, et al.
Nature Cancer
|
November 8, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors
Koichi Hirabayashi, Hongwei Du, Yang Xu, et al.
Cellular & Molecular Immunology
|
June 27, 2024
4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20
Zhangqi Dou, Thomas Raphael Bonacci, Peishun Shou, et al.
Cancer Immunology Research
|
September 14, 2019
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Christof C Smith, Shengjie Chai, Amber R Washington, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Expert Opinion on Biological Therapy
|
October 6, 2017
Treating hematological malignancies with cell therapy: where are we now?
Elisa Landoni, Barbara Savoldo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors
Giovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15
Yuhui Chen, Chuang Sun, Elisa Landoni, et al.
Journal for Immunotherapy of Cancer
|
September 14, 2021
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
Justin T Huckaby, Elisa Landoni, Timothy M Jacobs, et al.
Nature Cancer
|
April 26, 2021
GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision
Kai Wang, Yuhui Chen, Sarah Ahn, et al.
Bioengineering & Translational Medicine
|
November 29, 2023
Utilizing induced neural stem cell-based delivery of a cytokine cocktail to enhance chimeric antigen receptor-modified T-cell therapy for brain cancer
Alex S Woodell, Elisa Landoni, Alain Valdivia, et al.
Cancer Immunology Research
|
November 14, 2019
A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor
Elisa Landoni, Christof C Smith, Giovanni Fucá, et al.
Nature Cancer
|
November 8, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors
Koichi Hirabayashi, Hongwei Du, Yang Xu, et al.
Cellular & Molecular Immunology
|
June 27, 2024
4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20
Zhangqi Dou, Thomas Raphael Bonacci, Peishun Shou, et al.
Cancer Immunology Research
|
September 14, 2019
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Christof C Smith, Shengjie Chai, Amber R Washington, et al.
Page
of 3